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Lidocaine hydrochloride (HCl) is a water soluble weak acidic, local anaesthetic, usually administered by 
injection into the dermis layer of skin causes pain
1,2
. Alternatively an eutectic mixture of local anaesthetics 
(EMLA) may be unsuitable in emergency situations because a 1 hour time duration of permeation is 
necessary
3,4
. Low frequency sonophoresis (LFS) within a range of 20-100 kHz allows for the mechanism 
of inertial cavitation as the accepted theory for enhancing skin permeability
5,6
. Additionally a minimally 
invasive mechanism of microneedle assisted delivery of topical drugs produces microconduits to bypass 
the stratum corneum (SC) layer of skin
7
. Jacketed Franz diffusion cells (FDC) were implemented for ex-
vivo skin permeation studies of lidocaine NaCMC/GEL hydrogels post treatment by combined 
microneedle insertion followed by sonophoresis
8
. A lidocaine GEL to NaCMC mass ratio of 2.66 hydrogel 
treated with 18W LFS for a 10 minute duration combined with microneedle treatment of 5 minute duration 
resulted in a 4.8 fold average increase over 30 minutes when compared with LFS or passive diffusion 
alone. Minimum therapeutic levels of lidocaine HCl at 1.5 µg/ml were crossed after a period of 7 minutes 
post microneedle insertion of 5 mins and 18 W LFS for GEL to NaCMC mass ratio 2.66. A fairly 
significant and steady decline in the percentage of lidocaine HCl contained in skin from mass balance 
determination revealed lidocaine GEL to NaCMC mass ratio of 2.66 to possess 99.7% lidocaine HCl 
within 3 hours. This is likely caused by lidocaine HCl molecules diffusing faster through cavity formed 
cellular features in skin before systemic clearance in hypodermis or capillaries. The dispersion trends 
from zeta potential analysis favour lidocaine HCl GEL to NaCMC mass ratios from 1.6 to 2.3 compared 
with 2.66 of a lot more agglomeration. Increased GEL to NaCMC mass ratios resulted in fairly significant 
increases in mean particle size diameters despite polydispersity observed with all GEL to NaCMC mass 
ratios of lidocaine.      
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Fig. 2   Example of Particle size distribution 
of lidocaine NaCMC/gel hydrogels 
Fig. 1  Example of lidocaine HCl contained in skin from (F4) 
NaCMC/GEL 1:2.66 (  Passive diffusion), (  Microneedles, 3 
min), (    Microneedles, 5 min), (     LFS 5 min 15 W), (   LFS 10 
min 18 W), (      Microneedles + LFS) 
 
 
